The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
Abstract
BACKGROUND: Certain lactic acid bacteria may accelerate recovery from acute diarrhea. Lactobacillus reuteri is a commonly occurring Lactobacillus species with therapeutic potential in diarrhea. DESIGN: Prospective, randomized, placebo-controlled trial in two hospitals. METHODS: Children between 6 and 36 months of age admitted for rotavirus-associated diarrhea were randomized into three groups to receive either 10(10) or 10(7) colony-forming units (cfu) of L. reuteri or a matching placebo once a day for up to 5 days. RESULTS: The main effect of L. reuteri was on the duration of watery diarrhea. The mean (+/-SD) duration of watery diarrhea after initiation of treatment was 2.5 (1.5) days in the placebo group (n = 25) vs. 1.9 (0.9) days in the small dosage (n = 20) and 1.5 (1.1) days in the large dosage (n = 21) L. reuteri recipients (P = 0.01). By the second day of treatment watery diarrhea persisted in 80% of the placebo, 70% of the small dosage and 48% of the large dosage L. reuteri recipients (P = 0.04, large dosage vs. placebo). Stool cultures for lactobacilli confirmed that administration of L. reuteri resulted in good colonization of the GI tract. The mean (+/-SD) of total Lactobacillus count 2 days after treatment initiation was 2.8 (1.6) log 10 cfu/g in the placebo group, 4.5 (2.0) log 10 cfu/g in the small dosage L. reuteri group and 6.1 (1.2) log 10 cfu/g in the large dosage L. reuteri group (P = 0.0004). CONCLUSIONS: L. reuteri effectively colonized the gastrointestinal tract after administration and significantly shortened the duration of watery diarrhea associated with rotavirus. There was a correlation between the dosage of L. reuteri and the clinical effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., & Arvilommi, H. (1992) · Pediatric Research · doi:10.1203/00006450-199208000-00002 · Cited by 700
Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., & Koivula, T. (1991) · PubMed · Cited by 684
Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis
Majamaa, H., Isolauri, E., Saxelin, M., & Vesikari, T. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11561.x · Cited by 552
Self-citationProduction and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri
Talarico, T. L., Casas, I. A., Chung, T. C., & Dobrogosz, W. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1854 · Cited by 443
Self-citationLactobacillus reuteri as a Therapeutic Agent in Acute Diarrhea in Young Children
Shornikova, A.-V., Casas, I. A., Isolauri, E., Mykkänen, H., & Vesikari, T. (1997) · Journal of Pediatric Gastroenterology & Nutrition · doi:10.1097/00005176-199704000-00008 · Cited by 393
Self-citationImproved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG
Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., & Vesikari, T. (1995) · Vaccine · doi:10.1016/0264-410x(95)93319-5 · Cited by 370
Self-citationThe effects of Lactobacillus strains and oat fiber on methotrexate- induced enterocolitis in rats
Mao, Y., Nobaek, S., Kasravi, B., Adawi, D., Stenram, U., Molin, G., & Jeppsson, B. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690198 · Cited by 296
Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.
Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H., & Vesikari, T. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.1.51 · Cited by 287
Self-citationOral bacteriotherapy for viral gastroenteritis
Isolauri, E., Kaila, M., Mykkänen, H., Ling, W. H., & Salminen, S. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087695 · Cited by 269
Self-citationProduction of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri
Axelsson, L. T., Chung, T. C., Dobrogosz, W. J., & Lindgren, S. E. (1989) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v2i2.7449 · Cited by 262
Cited by
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
Servin, A. L. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.01.003 · Cited by 1,236
Probiotic bacteria: safety, functional and technological properties
Saarela, M., Mogensen, G., Fondén, R., Mättö, J., & Mattila-Sandholm, T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00375-8 · Cited by 1,202
Probiotics: an overview of beneficial effects
Ouwehand, A. C., Salminen, S., & Isolauri, E. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020620607611 · Cited by 1,013
Potential Uses of Probiotics in Clinical Practice
Reid, G., Jass, J., Sebulsky, M. T., & McCormick, J. K. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.658-672.2003 · Cited by 912
Metadata
- Authors
- SHORNIKOVA, A.-V., CASAS, I. A., MYKKÄNEN, H., SALO, E., & VESIKARI, T.
- Venue
- The Pediatric Infectious Disease Journal
- Published
- 1997-12
- Volume
- 16
- Issue
- 12
- Pages
- 1103-1107
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2050939953
- Cited by
- 318
- References
- 18
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. https://app.cochat.ai/papers/10.1097/00006454-199712000-00002
- The paper
- SHORNIKOVA, A.-V., CASAS, I. A., MYKKÄNEN, H., SALO, E., & VESIKARI, T. (1997). Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. The Pediatric Infectious Disease Journal. https://doi.org/10.1097/00006454-199712000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.